This Cochrane Clinical Answer compares gefitinib and afatinib versus other cytotoxic chemotherapy regimens in people with advanced epidermal growth factor receptor mutation non-small-cell lung cancer.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.